KEYNOTE 590 PEMBROLIZUMAB - AN OVERVIEW

This stops the activation of your T-cell which Usually would target and wipe out cancer. The cancer cells can then multiply and unfold. When Keytruda binds to the PD-1 receptor it prevents cancer cells from linking to and inactivating T-cells, enabling T-cell re-activation, and boosting the immune system's response against cancer. This affects the